Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Core EBITDA Margin

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Margin(%) 17.2820.8617.4515.5214.24

What is the latest Core EBITDA Margin ratio of MEDICAMEN BIOTECH ?

The latest Core EBITDA Margin ratio of MEDICAMEN BIOTECH is 17.28 based on Mar2023 Consolidated results.
Year Core EBITDA Margin
Mar202317.28
Mar202220.86
Mar202117.45
Mar202015.52
Mar201914.24

How is Core EBITDA Margin of MEDICAMEN BIOTECH Trending?

Years Core EBITDA Margin % Change
Mar2023 17.28
-17.16
Mar2022 20.86
19.54
Mar2021 17.45
12.44
Mar2020 15.52
8.99
Mar2019 14.24 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Core EBITDA Margin ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹735.5 Cr 33.4% 51% -17% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,452.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹113,132.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹106,191.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,512.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹95,954.5 Cr 2.2% -4.6% 86.6% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

33.4%

51%

-17%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses